Boston, MA, United States of America

Robert Neil Hunter, Iii


Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Research Triangle Park, NC (US) (2016)
  • Boston, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Robert Neil Hunter, III

Introduction

Robert Neil Hunter, III is a notable inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the development of glucagon-receptor selective polypeptides. With a total of four patents to his name, Hunter's work has the potential to impact therapeutic approaches for various metabolic disorders.

Latest Patents

One of Hunter's latest patents is focused on glucagon-receptor selective polypeptides and methods of use thereof. This invention pertains to isolated polypeptides that are glucagon-receptor selective analogs and peptide derivatives. These analogs demonstrate improved solubility, thermal stability, and physicochemical properties compared to native endogenous glucagon. The invention also encompasses methods for utilizing these polypeptides in therapeutic and diagnostic applications. They are particularly useful in treating obesity, diabetes, metabolic disorders, and other related diseases.

Career Highlights

Throughout his career, Robert Neil Hunter, III has worked with prominent companies in the biotechnology sector. Notable among these are Intarcia Therapeutics, Inc. and I2O Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Hunter has collaborated with esteemed colleagues such as Ved P. Srivastava and Steven Thomas Dock. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

Robert Neil Hunter, III is a distinguished inventor whose work in glucagon-receptor selective polypeptides holds promise for advancing treatments for metabolic disorders. His contributions to biotechnology continue to pave the way for innovative therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…